TrialLupus science & medicine2026

Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials.

Andrea Doria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.